Exactly! That is why I see the allowance of patients with less severe eyesight loss as a major decision by the regulators of this trial and a good sign. The earlier the procedure, the more beneficial to the patients of this trial. To be able to stop the progression of eyesight deteriation is huge and when/if approved, will be prescribed at the earliest sign of diagnosis. This in itself is a home run. --- To restore vision lost is a Grand Slam!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.